Clinical Trial Update: Study to Evaluate Two Lenalidomide Dose Regimens With Low Dose Dexamethasone for the Treatment Relapsed Multiple Myeloma [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating two lenalidomide dose regimens with low-dose dexamethasone for relapsed multiple myeloma has completed and posted results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Myeloma

Drugs mentioned

• Lenalidomide (lenalidomide)
• low-dose dexamethasone (dexamethasone)

Snippet

Sponsor: Boston VA Research Institute, Inc. | Conditions: Multiple Myeloma | Phase 2 | Status: COMPLETED | Results posted: 2021-01-25